Alerts

Recall for product correction due to potential for interruption of insulin delivery and/or infection due to needle breaking during use.

Multiple devices which use auto servo ventilation/Adaptive Servo-Ventilation (ASV) therapy have been subject to recall actions.

Recall for product correction due to increased risk of death for patients with symptomatic chronic heart failure.

The TGA has reviewed laparoscopic power morcellators and updated safety information to ensure their use aligns with current advice, including warnings about cancer risks and the need for containment systems during surgery.

Ja Dera 100% Natural Weight Loss Supplement capsules pose a serious risk to your health and should not be taken

No evidence to support routine blood monitoring at this time

Slim Fit capsules pose a serious risk to your health and should not be taken

Recall for product correction due to additional affected devices.

Final update - no definite link established

Recall as pumps will cease operation on 1 January 2016.

Recall - risk of adverse events due to unacceptably high level of arsenic

Update - adverse event monitoring

Hazard alert due to multiple potential safety issues.

Recall for product correction due to fire risk from faulty component.

Recall for product correction due to fire risk from faulty component.

The following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)

Recall - bottles supplied without child-resistant caps

Recall for product correction due to risk of sparking or fire due to damaged or cut wire.

Safety advisory

Recall for product correction due to potential for insulin to not be delivered as intended.

Recall due to counterfeit products may have defects and not be effective.

Safety advisory

Safety advisory

Safety advisory

Safety advisory